Ryosuke Tateishi Selected Research

Alanine Transaminase (SGPT)

4/2022	Development of novel deep multimodal representation learning-based model for the differentiation of liver tumors on B-mode ultrasound images.
10/2011	Prediction of hepatocellular carcinoma development by plasma ADAMTS13 in chronic hepatitis B and C.
9/2011	Influence of serum HBV DNA load on recurrence of hepatocellular carcinoma after treatment with percutaneous radiofrequency ablation.
1/2003	Congenital absence of portal vein with multiple hyperplastic nodular lesions in the liver.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryosuke Tateishi Research Topics

Disease

87	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 05/2004
42	Neoplasms (Cancer) 04/2022 - 01/2003
17	Chronic Hepatitis C 07/2021 - 07/2004
13	Fibrosis (Cirrhosis) 01/2022 - 09/2008
13	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 12/2005
12	Liver Diseases (Liver Disease) 01/2022 - 02/2007
9	Infections 01/2021 - 04/2005
6	Non-alcoholic Fatty Liver Disease 01/2022 - 12/2018
6	Neoplasm Metastasis (Metastasis) 03/2013 - 11/2008
5	Thrombocytopenia (Thrombopenia) 01/2022 - 08/2010
5	Hepatitis C 01/2022 - 01/2009
5	Carcinogenesis 01/2022 - 04/2005
5	Liver Neoplasms (Liver Cancer) 09/2020 - 07/2004
4	Hemorrhage 01/2022 - 04/2016
4	Disease Progression 01/2020 - 01/2012
3	Necrosis 04/2022 - 01/2012
3	Obesity 07/2021 - 01/2018
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 10/2009
2	Cholecystitis 09/2021 - 08/2020
2	Cholangitis 09/2021 - 04/2017
2	Hypertension (High Blood Pressure) 01/2021 - 04/2017
2	Drug-Related Side Effects and Adverse Reactions 08/2020 - 10/2014
2	Virus Diseases (Viral Diseases) 12/2019 - 01/2012
2	Cholangiocarcinoma 09/2019 - 12/2017
2	Pain (Aches) 09/2017 - 03/2011
2	Chronic Hepatitis (Chronic Active Hepatitis) 06/2015 - 01/2003
2	Hepatitis 01/2009 - 01/2008
1	Thyroid Neoplasms (Thyroid Cancer) 09/2021
1	Pancreatitis 09/2021
1	Inflammation (Inflammations) 09/2021
1	Dyslipidemias (Dyslipidemia) 07/2021

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 04/2022 - 11/2008
13	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2004
10	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022 - 05/2005
10	Tumor Biomarkers (Tumor Markers)IBA 09/2019 - 12/2006
9	InterferonsIBA 07/2021 - 05/2004
7	AlbuminsIBA 04/2022 - 05/2005
7	Ethanol (Ethyl Alcohol)IBA 01/2018 - 11/2004
5	Indicators and Reagents (Reagents)IBA 03/2019 - 08/2008
5	acarboxyprothrombin (PIVKA)IBA 01/2014 - 05/2005
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2022 - 01/2003
4	Alanine Transaminase (SGPT)IBA 04/2022 - 01/2003
4	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 08/2012
4	lentil lectinIBA 01/2014 - 12/2006
3	Pharmaceutical PreparationsIBA 01/2022 - 04/2005
3	lusutrombopagIBA 01/2022 - 02/2019
3	lenvatinibIBA 09/2021 - 01/2020
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 02/2011
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2012
3	Serum AlbuminIBA 01/2020 - 02/2007
3	LipidsIBA 01/2019 - 01/2018
3	Messenger RNA (mRNA)IBA 12/2018 - 05/2014
3	Interleukin-6 (Interleukin 6)IBA 02/2015 - 11/2009
3	AntigensIBA 11/2014 - 06/2011
3	orantinib (SU6668)IBA 10/2014 - 02/2011
3	Prothrombin (Factor II)IBA 04/2012 - 09/2008
2	Blood Proteins (Serum Proteins)IBA 01/2021 - 04/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 08/2020
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 10/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2018
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2021 - 02/2012
2	EnzymesIBA 09/2020 - 04/2005
2	acylcarnitineIBA 01/2019 - 01/2018
2	Hyaluronic Acid (Hyaluronan)IBA 07/2018 - 06/2011
2	IronIBA 01/2018 - 04/2016
2	Ferritins (Ferritin)IBA 01/2018 - 04/2016
2	AdiponectinIBA 02/2015 - 11/2011
2	RNA (Ribonucleic Acid)IBA 10/2014 - 04/2005
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2014 - 02/2011
2	Angiogenesis InhibitorsIBA 10/2014 - 02/2011
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2014 - 02/2011
2	Mitochondrial Form Creatine KinaseIBA 08/2014 - 05/2014
2	Contrast MediaIBA 01/2013 - 01/2010
2	Fluorouracil (Carac)FDA LinkGeneric 10/2012 - 05/2006
2	SonazoidIBA 04/2012 - 04/2011
2	Fetal Proteins (Fetoprotein)IBA 04/2012 - 10/2011
2	DNA (Deoxyribonucleic Acid)IBA 09/2011 - 11/2008
1	SREBP cleavage-activating proteinIBA 01/2022
1	N-propionyl-L-valine (A 195)IBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	clonidine-displacing substance (ClDS)IBA 01/2022
1	Sterol Regulatory Element Binding ProteinsIBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Translationally-Controlled 1 Tumor ProteinIBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021

Therapy/Procedure

42	Radiofrequency Ablation 04/2022 - 11/2004
35	Therapeutics 04/2022 - 05/2004
5	Hepatectomy 01/2022 - 01/2010
5	Drug Therapy (Chemotherapy) 01/2022 - 11/2010
4	Liver Transplantation 02/2015 - 05/2005
3	Platelet Transfusion (Blood Platelet Transfusions) 01/2022 - 12/2019
3	Aftercare (After-Treatment) 09/2021 - 09/2011
3	Renal Dialysis (Hemodialysis) 01/2019 - 10/2009
2	Molecular Targeted Therapy 01/2021 - 09/2019
2	Neoadjuvant Therapy 09/2020 - 11/2010
2	Catheters 10/2012 - 01/2010
1	Chemoprevention 01/2022
1	Bariatric Surgery 01/2022
1	Immunotherapy 01/2021